BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1785366)

  • 1. [Viral infections in intravenous drug addicts. Clinical and prognostic significance].
    Glória H; Ramalho F; Marinho R; Pedro M; Velosa J; Moura MC
    Acta Med Port; 1991; 4(5):263-7. PubMed ID: 1785366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan.
    Chu FY; Chiang SC; Su FH; Chang YY; Cheng SH
    J Med Virol; 2009 Jun; 81(6):973-8. PubMed ID: 19382252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices.
    Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Carballo E; Barrio E
    Hepatogastroenterology; 2003; 50(54):2093-7. PubMed ID: 14696471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
    J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Seroprevalence of delta virus and hepatitis C virus in patients with chronic infection with hepatitis B virus].
    de Miguel J; Collazos J; Mayo J; López de Goicoechea MJ; Echániz C; Mendarte U
    Rev Clin Esp; 1994 Oct; 194(10):897-900. PubMed ID: 7800870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.
    Shirin T; Ahmed T; Iqbal A; Islam M; Islam MN
    J Health Popul Nutr; 2000 Dec; 18(3):145-50. PubMed ID: 11262767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and epidemiological significance of hepatitis delta virus (HDV) infection in chronic HBV carriers in Portugal.
    Ramalho F; Carvalho G; Bonino F; Baptista A; de Moura MC
    Prog Clin Biol Res; 1987; 234():409-17. PubMed ID: 3628400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of transfusion associated infections in multitransfused children in relation to mandatory screening of HIV in donated blood.
    Aggarwal V; Prakash C; Yadav S; Chattopadhya D
    Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):699-706. PubMed ID: 9656388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus in three groups of populations at high risk of HIV infection in Amritsar (Punjab), Northern India.
    Jindal N; Arora U; Singh K
    Jpn J Infect Dis; 2008 Jan; 61(1):79-81. PubMed ID: 18219142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers.
    Liaw YF; Tsai SL; Sheen IS; Chao M; Yeh CT; Hsieh SY; Chu CM
    Am J Gastroenterol; 1998 Mar; 93(3):354-9. PubMed ID: 9517639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infection by HIV and the hepatitis B, C, and D viruses in intravenous drug addicts. Seroprevalence at 1 year and its follow-up].
    Delgado-Iribarren A; Wilhelmi I; Padilla B; Cañedo T; Gómez J; Elviro J
    Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):8-13. PubMed ID: 8384891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
    Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Galimany R; Esteban R; Guardia J
    Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
    Khan A; Kurbanov F; Tanaka Y; Elkady A; Sugiyama M; Dustov A; Mizokami M
    J Med Virol; 2008 Feb; 80(2):268-76. PubMed ID: 18098133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hepatitis G virus RNA in human immunodeficiency virus type 1-positive intravenous drug users.
    Zehender G; De Maddalena C; Bosisio AB; Gianotto M; Santambrogio S; Moroni M; Galli M
    J Hum Virol; 1998; 1(2):96-100. PubMed ID: 10195238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.